[Discussion] can we stop arguing about state board until somebody posts a number
can we stop arguing about state board until somebody posts a number. I would rather ask a basic question now than get this wrong quietly for two months.
Compounded preparations are not approved products and carry no bioequivalence claim. That is a statement about regulatory category, not about quality.
The shortage list is the legal hinge: the permissions that allow certain compounding to happen at scale are tied to a drug’s shortage status, which changes.
A beyond-use date derived from published stability data means something different from one assigned by default rule. Asking which is a fair question and the answer is usually available.
I will update this if the picture changes rather than quietly leaving it up.
best — the order this archive was captured in
Nothing in this thread is medical advice, and the choice between arrangements is one for you and a prescriber who knows your history.
Potency and sterility testing on the finished preparation are separate from any certificate covering the starting material. Ask which you are being shown.
compounded is not generic, there is no equivalence claim
Who is the prescriber, and are they the same organisation as the pharmacy?
salt forms are the recurring argument and the answer is boring
if a clinic will not name the facility, that is your answer
What concentration is on the label, and does it match what you were expecting?
a telehealth intake that asks nothing has told you what it is
503A or 503B — do you know which?
Asked for the beyond-use date basis and got a real answer with a stability reference attached. Not universal, apparently.
Not convinced. You are comparing a compounded concentration with a branded one and assuming they match.